Linscomb & Williams, Inc. Becton Dickinson & CO Transaction History

Linscomb & Williams, Inc.

$2.13 Billion
Q2 2025

A detailed history of Linscomb & Williams, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Linscomb & Williams, Inc. holds 11,745 shares of BDX stock, worth $2.27 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

11,745

Previous 10,855 8.2%

Holding current value

$2.27 Million

Previous $2.49 Million 18.62%

% of portfolio

0.1%

Previous 0.13%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	$165.15 - $226.42 $146,983 - $201,513	890 Added 8.2%	11,745 $2.02 Million
Q1 2025 May 12, 2025	BUY	$222.79 - $249.08 $225,240 - $251,819	1,011 Added 10.27%	10,855 $2.49 Million
Q4 2024 Feb 05, 2025	BUY	$220.02 - $243.75 $63,585 - $70,443	289 Added 3.02%	9,844 $2.23 Million
Q3 2024 Nov 06, 2024	SELL	$221.47 - $242.41 $11,516 - $12,605	-52 Reduced 0.54%	9,555 $2.3 Million
Q2 2024 Aug 07, 2024	BUY	$225.07 - $246.17 $53,341 - $58,342	237 Added 2.53%	9,607 $2.25 Million
Q1 2024 May 14, 2024	SELL	$233.45 - $247.73 $118,359 - $125,599	-507 Reduced 5.13%	9,370 $2.32 Million
Q4 2023 Feb 06, 2024	SELL	$232.24 - $267.23 $4,877 - $5,611	-21 Reduced 0.21%	9,877 $2.41 Million
Q3 2023 Oct 10, 2023	SELL	$254.9 - $283.59 $11,470 - $12,761	-45 Reduced 0.45%	9,898 $2.56 Million
Q2 2023 Aug 09, 2023	BUY	$238.39 - $265.32 $9,297 - $10,347	39 Added 0.39%	9,943 $2.63 Million
Q1 2023 May 11, 2023	BUY	$229.71 - $259.35 $28,484 - $32,159	124 Added 1.27%	9,904 $2.45 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $140,360 - $165,193	643 Added 7.04%	9,780 $2.49 Million
Q3 2022 Nov 09, 2022	BUY	$51.03 - $264.23 $1,326 - $6,869	26 Added 0.29%	9,137 $2.04 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $52,347 - $61,418	-223 Reduced 2.39%	9,111 $2.25 Million
Q1 2022 May 17, 2022	BUY	$243.64 - $270.48 $66,757 - $74,111	274 Added 3.02%	9,334 $2.48 Million
Q4 2021 Feb 10, 2022	BUY	$230.08 - $250.94 $115,730 - $126,222	503 Added 5.88%	9,060 $2.28 Million
Q3 2021 Nov 03, 2021	BUY	$232.72 - $256.47 $125,901 - $138,750	541 Added 6.75%	8,557 $2.1 Million
Q2 2021 Aug 10, 2021	BUY	$232.65 - $254.58 $99,806 - $109,214	429 Added 5.65%	8,016 $1.95 Million
Q1 2021 May 12, 2021	BUY	$232.09 - $256.88 $146,680 - $162,348	632 Added 9.09%	7,587 $1.85 Million
Q4 2020 Feb 11, 2021	BUY	$221.92 - $245.94 $150,683 - $166,993	679 Added 10.82%	6,955 $1.74 Million
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $60,415 - $77,492	280 Added 4.67%	6,276 $1.46 Million
Q2 2020 Aug 11, 2020	BUY	$219.9 - $263.41 $493,895 - $591,618	2,246 Added 59.89%	5,996 $1.44 Million
Q1 2020 May 11, 2020	BUY	$195.69 - $279.01 $92,757 - $132,250	474 Added 14.47%	3,750 $862,000
Q4 2019 Feb 13, 2020	BUY	$236.45 - $266.82 $26,718 - $30,150	113 Added 3.57%	3,276 $891,000
Q3 2019 Nov 08, 2019	SELL	$230.58 - $256.08 $3,458 - $3,841	-15 Reduced 0.47%	3,163 $800,000
Q2 2019 Aug 06, 2019	BUY	$217.4 - $246.08 $23,261 - $26,330	107 Added 3.48%	3,178 $801,000
Q1 2019 May 09, 2019	BUY	$206.05 - $248.17 $1,648 - $1,985	8 Added 0.26%	3,071 $767,000
Q4 2018 Feb 08, 2019	SELL	$204.73 - $257.93 $35,213 - $44,363	-172 Reduced 5.32%	3,063 $690,000
Q3 2018 Nov 08, 2018	SELL	$233.07 - $256.0 $4,428 - $4,864	-19 Reduced 0.58%	3,235 $844,000
Q2 2018 Aug 07, 2018	BUY	$208.1 - $233.85 $12,069 - $13,563	58 Added 1.81%	3,254 $779,000
Q1 2018 May 04, 2018	SELL	$205.46 - $240.27 $21,162 - $24,747	-103 Reduced 3.12%	3,196 $693,000
Q4 2017 Feb 02, 2018	SELL	$189.0 - $222.64 $24,948 - $29,388	-132 Reduced 3.85%	3,299 $706,000
Q3 2017 Oct 27, 2017	BUY	$186.89 - $198.9 $641,219 - $682,425	3,431	3,431 $672,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

260M

Call Options Held

1.82M

Put Options Held

696K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $55.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linscomb & Williams, Inc. with notifications on news.

Account

Linscomb & Williams, Inc. Becton Dickinson & CO Transaction History